Mankind Pharma Limited proposes to open its initial public offering of 40,058,844 Equity Shares on Tuesday, April 25, 2023. Bid/ Offer Closing Date will be Thursday, April 27, 2023. The Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, that is, April 24, 2023. The Price Band of the Offer has been fixed from ₹ 1,026 per Equity Share to ₹ 1,080 per Equity Share. Bids can be made for a minimum of 13 Equity Shares and in multiples of 13 Equity Shares thereafter.
- Issue Opens on: Tuesday, April 25, 2023
- Issue Closes on: Thursday, April 27, 2023
- Issue Type: Book Built Issue IPO
- Price Band: ₹1026 to ₹1080 per Equity Share
- Face Value: ₹ 1 per equity share
- Lot Size: 13 Shares and multiples
- Issue Size: 40,058,844 shares
The offer of 40,058,844 equity shares comprises an offer for sale of 3,705,443 equity shares by Ramesh Juneja; 3,505,149 equity shares by Rajeev Juneja; 2,804,119 equity shares by Sheetal Arora; 17,405,559 equity shares by Cairnhill CIPEF Limited; 2,623,863 equity shares by Cairnhill CGPE Limited; 9,964,711 equity shares by Beige Limited; and 50,000 equity shares by Link Investment Trust.
The Offer is being made through the Book Building Process wherein not more than 50% of the Offer shall be available for allocation on a proportionate basis to QIBs, provided that the Company and the Selling Shareholders, in consultation with the BRLMs, may allocate up to 60% of the QIB Portion to Anchor Investors and the basis of such allocation will be on a discretionary basis by the Company and the Selling Shareholders, in consultation with the BRLMs, of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids.
The Equity Shares offered through Red Herring Prospectus are proposed to be listed on both BSE and NSE. Kotak Mahindra Capital Company Limited, Axis Capital Limited, IIFL Securities Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited are the Book Running Lead Managers to the Offer.
